SARDH
Basic information
Region (hg38): 9:133663560-133739955
Previous symbols: [ "DMGDHL1" ]
Links
Phenotypes
GenCC
Source:
- sarcosinemia (Supportive), mode of inheritance: AR
- sarcosinemia (Limited), mode of inheritance: Unknown
- sarcosinemia (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SARDH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 13 | 26 | |||
missense | 65 | 10 | 82 | |||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 0 | |||||
Total | 0 | 1 | 65 | 24 | 20 |
Variants in SARDH
This is a list of pathogenic ClinVar variants found in the SARDH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-133663914-T-C | not specified | Uncertain significance (Dec 20, 2021) | ||
9-133663932-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
9-133664010-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
9-133666739-C-T | not specified | Uncertain significance (Aug 26, 2022) | ||
9-133666754-T-C | not specified | Likely benign (Dec 02, 2022) | ||
9-133666765-G-A | Likely benign (Aug 01, 2022) | |||
9-133666768-G-A | SARDH-related disorder | Likely benign (Apr 29, 2019) | ||
9-133666770-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
9-133666782-C-T | not specified | Likely benign (Jul 09, 2021) | ||
9-133666783-G-C | not specified | Uncertain significance (Jul 27, 2021) | ||
9-133666831-G-A | SARDH-related disorder | Likely benign (Dec 24, 2019) | ||
9-133670611-C-T | not specified | Uncertain significance (Jan 07, 2022) | ||
9-133670612-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
9-133670615-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
9-133670624-C-T | Benign (Dec 31, 2019) | |||
9-133670630-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
9-133670635-T-C | not specified | Uncertain significance (Aug 23, 2021) | ||
9-133670668-G-T | not specified | Uncertain significance (May 07, 2024) | ||
9-133670733-C-T | Benign (Feb 01, 2024) | |||
9-133670734-G-A | Likely benign (Jul 01, 2023) | |||
9-133670747-G-A | not specified | Uncertain significance (Nov 13, 2023) | ||
9-133671557-G-A | SARDH-related disorder | Benign (Oct 17, 2019) | ||
9-133671564-C-T | not specified | Uncertain significance (Aug 08, 2022) | ||
9-133671600-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
9-133671601-C-T | not specified | Uncertain significance (Mar 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SARDH | protein_coding | protein_coding | ENST00000371872 | 20 | 76396 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.27e-16 | 0.917 | 125455 | 0 | 293 | 125748 | 0.00117 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.679 | 561 | 608 | 0.923 | 0.0000407 | 5870 |
Missense in Polyphen | 194 | 245.77 | 0.78936 | 2404 | ||
Synonymous | 0.102 | 262 | 264 | 0.992 | 0.0000192 | 1872 |
Loss of Function | 2.23 | 32 | 48.8 | 0.655 | 0.00000285 | 471 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00203 | 0.00195 |
Ashkenazi Jewish | 0.00190 | 0.00189 |
East Asian | 0.000502 | 0.000489 |
Finnish | 0.00334 | 0.00329 |
European (Non-Finnish) | 0.00112 | 0.00111 |
Middle Eastern | 0.000502 | 0.000489 |
South Asian | 0.000462 | 0.000457 |
Other | 0.000981 | 0.000978 |
dbNSFP
Source:
- Disease
- DISEASE: Sarcosinemia (SARCOS) [MIM:268900]: A metabolic disorder characterized by an increased concentration of sarcosine in plasma and an increased excretion of sarcosine in urine. Sarcosinemia is most probably a benign condition without significant clinical problems. Some reports have associated sarcosinemia with mental retardation and neurologic problems. {ECO:0000269|PubMed:10444331, ECO:0000269|PubMed:22825317}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glycine, serine and threonine metabolism - Homo sapiens (human);3-Phosphoglycerate dehydrogenase deficiency;Non Ketotic Hyperglycinemia;Glycine and Serine Metabolism;sarcosine oncometabolite pathway ;Dimethylglycine Dehydrogenase Deficiency;Hyperglycinemia, non-ketotic;Dimethylglycine Dehydrogenase Deficiency;Sarcosinemia;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);One carbon metabolism and related pathways;Metabolism of amino acids and derivatives;Metabolism;Choline catabolism;glycine betaine degradation;superpathway of choline degradation to L-serine;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.317
Intolerance Scores
- loftool
- 0.115
- rvis_EVS
- 1.41
- rvis_percentile_EVS
- 94.81
Haploinsufficiency Scores
- pHI
- 0.365
- hipred
- Y
- hipred_score
- 0.755
- ghis
- 0.441
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.887
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sardh
- Phenotype
Gene ontology
- Biological process
- choline catabolic process;oxidation-reduction process;sarcosine catabolic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial matrix
- Molecular function
- sarcosine dehydrogenase activity;oxidoreductase activity